On March 29, 2026, Insilico Medicine (Insilico), a clinical-stage biotechnology company powered by generative artificial intelligence (AI) and automation, announced a drug discovery collaboration with…Read More
Wilson Sonsini Advises Insilico on Global R&D Collaboration with Lilly
Related Posts
Add A Comment
